SCHEMBL3047637

SCHEMBL3047637

N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)NCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 6/20 0.71
BLM P54132 4/20 0.71
ALDH1A1 P00352 4/20 0.71
LMNA P02545 4/20 0.71
TSHR P16473 4/20 0.71
HTR1A P08908 4/20 0.71
HTR2A P28223 4/20 0.71
HTR2C P28335 4/20 0.71
HTR2B P41595 4/20 0.71
KDM4E B2RXH2 4/20 0.71
MAPT P10636 4/20 0.71
NFKB1 P19838 3/20 0.71
PMP22 Q01453 3/20 0.71
CYP3A4 P08684 3/20 0.71
KMT2A Q03164 3/20 0.71
HTR7 P34969 2/20 0.71
ADORA3 P0DMS8 1/20 0.71
ALOX15 P16050 1/20 0.71
SLC6A4 P31645 1/20 0.71
MTOR P42345 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28788031 1.00 NPSR1 (0.71) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL10407441 0.87 NPSR1 (0.69) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL10407439 0.87 NPSR1 (0.69) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL3073308 0.86 NPSR1 (0.65) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL5121693 0.86 NPSR1 (0.67) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL29804259 0.86 HDAC8 (0.77) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL20168578 0.86 HDAC8 (0.77) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL20168582 0.86 HDAC8 (0.77) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL20271388 0.84 HTR2C (0.72) NPSR1BLMALDH1A1LMNATSHR
SCHEMBL8699875 0.84 KDM4E (0.69) BLMLMNATSHRHTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2983473-A2 PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF ALS Mountain Llc (US) 2016-02-17 EP claimed
US-20140350064-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF ALS MOUNTAIN LLC 2014-11-27 US claimed
WO-2014144130-A2 PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF ALS MOUNTAIN LLC (US) 2014-09-18 WO claimed
US-20120183600-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS CHEN CHIEN-HUNG (US) 2012-07-19 US claimed
EP-1789052-A4 COMPOSITION AND METHOD FOR INDUCING OR RESTORING LOCOMOTOR FUNCTIONS IN AN ANIMAL UNIV LAVAL (CA) 2008-05-21 EP claimed
US-20080096847-A1 Composition And Method For Inducing Or Restoring Locomotor Functions In An Animal UNIVERSITE LAVAL 2008-04-24 US claimed
EP-1789052-A1 COMPOSITION AND METHOD FOR INDUCING OR RESTORING LOCOMOTOR FUNCTIONS IN AN ANIMAL Université Laval (CA) 2007-05-30 EP claimed
WO-2006026850-A1 COMPOSITION AND METHOD FOR INDUCING OR RESTORING LOCOMOTOR FUNCTIONS IN AN ANIMAL UNIVERSITE LAVAL (CA) 2006-03-16 WO claimed
US-20030187055-A1 Synergistic pharmaceutical combinations for treating obesity BANK OF AMERICA, N.A., AS AGENT 2003-10-02 US claimed
US-20030162725-A1 Synergistic pharmaceutical combinations for treating obesity with EGCG BANK OF AMERICA, N.A., AS AGENT 2003-08-28 US claimed
US-6579899-B1 Precursor or prodrug of serotonin, tryptophan or 5-hydroxytryptophan MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2003-06-17 US claimed
WO-2002038141-A9 COMPOSITIONS AND METHODS FOR TREATMENT OF MILD COGNITIVE IMPAIRMENT MASSACHUSETTS INST TECHNOLOGY (US) 2003-02-13 WO claimed
US-20020173549-A1 Compositions and methods for treatment of mild cognitive impairment NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-11-21 US claimed
EP-1253915-A1 METHOD FOR TREATING STRESS WITH A PRECURSOR OF SEROTONIN Massachusetts Institute of Technology (US) 2002-11-06 EP claimed
WO-2002038141-A2 COMPOSITIONS AND METHODS FOR TREATMENT OF MILD COGNITIVE IMPAIRMENT MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-05-16 WO claimed
WO-2001054681-A2 COMPOSITION FOR TREATMENT OF STRESS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-08-02 WO claimed
US-10934429-B2 Polycarbonate compositions having improved adhesion to polyurethane layers COVESTRO DEUTSCHLAND AG (DE) 2021-03-02 US disclosed
US-20190153218-A1 POLYCARBONATE COMPOSITIONS HAVING IMPROVED ADHESION TO POLYURETHANE LAYERS COVESTRO DEUTSCHLAND AG (DE) 2019-05-23 US disclosed
US-4024050-A Phosphorous ester antifoulants in crude oil refining NALCO CHEMICAL COMPANY (US) 1977-05-17 US disclosed
US-3974219-A PREPARATION PEPTIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-08-10 US disclosed